MedTrace Logo

MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease

NCT06181474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-05-04

No results posted yet for this study

Summary

The goal of this observational study is to understand if there is a correlation between the evolution of MELD-Na and symptomatic burden of patients with advanced chronic liver disease.

All patients with chronic liver disease will be invited to participate in the study. Patients will be followed prospectively with assessment of their MELD-Na score and symptom burden, according to the Edmonton Symptom Assessment System scale.

Conditions

  • Palliative Care
  • End Stage Liver DIsease

Interventions

OTHER

ESAS

Observation of symptoms

Sponsors & Collaborators

  • Unidade Local de Saúde de Matosinhos, EPE

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-31
Completion
2025-01-25

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06181474 on ClinicalTrials.gov